Pfizer Inc. (PFE)
Pfizer Inc. is a global pharmaceutical company known for its research and development of innovative medicines and vaccines. Founded in 1849, it has a diverse portfolio that includes treatments for various medical conditions, and it played a key role in developing one of the first COVID-19 vaccines. Pfizer operates in multiple healthcare sectors, including biopharmaceuticals, oncology, and immunology.
Dividend History
Investors can expect a dividend payout of $0.43 per share, scheduled to be distributed in 10 days on December 1, 2025
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 1, 2025 | $0.43 | 2025-11-07 | 2025-11-07 |
| September 2, 2025 | $0.43 | 2025-07-25 | 2025-07-25 |
| June 13, 2025 | $0.43 | 2025-05-09 | 2025-05-09 |
| March 7, 2025 | $0.43 | 2025-01-24 | 2025-01-24 |
| December 2, 2024 | $0.42 | 2024-11-08 | 2024-11-08 |
Dividends Summary
- Pfizer Inc. has issued 88 dividend payments over the past 21 years
- The most recent dividend was paid 80 days ago, on September 2, 2025
- The highest dividend payed out to investors during this period was $0.43 per share
- The average dividend paid during this period was $0.30 per share.
Company News
Pfizer's high dividend yield of 6.9% remains safe for now, but investors are cautious about the company's future growth prospects following reduced COVID-19 product sales and potential upcoming patent challenges.
The global polycystic ovary syndrome (PCOS) treatment market is projected to grow from USD 4.83 billion in 2024 to USD 9.12 billion by 2034, with a 6.56% CAGR. North America currently dominates the market, with Asia-Pacific expected to witness the fastest growth.
Novo Nordisk underwent a significant board restructuring, with Lars Rebien Sorensen elected as chair, consolidating the Novo Nordisk Foundation's voting power to 77% while holding only 28% of share capital, sparking governance concerns among minority shareholders.
The article highlights three potentially undervalued stocks for investors heading into 2026: Pfizer, Newmont, and Utz Brands, analyzing their current market positions, strategic developments, and potential growth opportunities.
